Search Results 2541-2550 of 25233 for oral
Patients must have pathologically confirmed, previously untreated, unresected squamous cell carcinoma of the larynx, hypopharynx, oropharynx, oral cavity ...
easily understand the candidate's oral and written communication in order to effectively evaluate performance and to work collaboratively in the care of.
Patients on oral thrombin inhibitors including Dabigatran and oral factor X a inhibitors such as rivaroxaban, apixaban and edoxaban, unless discontinued for ...
... oral antibiotic therapy or have had at least two episodes of severe CDI resulting in hospitalization may be eligible for the study. Subjects may receive a ...
The co-authors are anesthesiologists David Barbara, M.D., and William Mauermann, M.D.; Christopher Viozzi, D.D.S., M.D., an oral and maxillofacial surgeon ...
Inability to swallow oral meds or gastrointestinal disorder that might interfere with absorption of oral drugs; Major surgery within 28 days of first receipt ...
Na · Nabi-HB. Also known as. Hepatitis b immune globulin (intramuscular route, intravenous route) · Nabi-HB NovaPlus. Also known as · Nabilone (oral route).
The purpose of this study is to collect safety, effectiveness and pharmacokinetics (in a subgroup of subjects) data on the use of NX9 as an oral CT contrast ...
... oral boards, an annual oral examination in clinical neurosurgery and neurology is administered. The format mirrors that of the certifying oral ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.